aranesp

Generic: darbepoetin alfa

Labeler: amgen inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name aranesp
Generic Name darbepoetin alfa
Labeler amgen inc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS SUBCUTANEOUS
Active Ingredients

darbepoetin alfa 60 ug/.3mL

Manufacturer
Amgen Inc

Identifiers & Regulatory

Product NDC 55513-023
Product ID 55513-023_317b2b26-f30d-4a72-8667-780806d4c5b5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA103951
Listing Expiration 2026-12-31
Marketing Start 2006-08-14

Pharmacologic Class

Established (EPC)
erythropoiesis-stimulating agent [epc]
Chemical Structure
erythropoietin [cs]
Physiologic Effect
increased erythroid cell production [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55513023
Hyphenated Format 55513-023

Supplemental Identifiers

RxCUI
349273 349274 349275 349276 352044 352045 352046 352047 730044 730046 731167 731171 731174 731176 731179 731181 731184 731227 731229 731231 731235 731241 731245 731250 1605171 1605172 1654954 1654955
UPC
0355513006019
UNII
15UQ94PT4P
NUI
N0000175665 M0007726 N0000009319

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aranesp (source: ndc)
Generic Name darbepoetin alfa (source: ndc)
Application Number BLA103951 (source: ndc)
Routes
INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 60 ug/.3mL
source: ndc
Packaging
  • 1 BLISTER PACK in 1 PACKAGE (55513-023-04) / 4 SYRINGE in 1 BLISTER PACK / .3 mL in 1 SYRINGE (55513-023-01)
source: ndc

Packages (1)

55513-023-04 1 BLISTER PACK in 1 PACKAGE (55513-023-04) / 4 SYRINGE in 1 BLISTER PACK / .3 mL in 1 SYRINGE (55513-023-01)

Ingredients (1)

darbepoetin alfa (60 ug/.3mL)

Linked Drug Pages (1)

ARANESP ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "317b2b26-f30d-4a72-8667-780806d4c5b5", "openfda": {"nui": ["N0000175665", "M0007726", "N0000009319"], "upc": ["0355513006019"], "unii": ["15UQ94PT4P"], "rxcui": ["349273", "349274", "349275", "349276", "352044", "352045", "352046", "352047", "730044", "730046", "731167", "731171", "731174", "731176", "731179", "731181", "731184", "731227", "731229", "731231", "731235", "731241", "731245", "731250", "1605171", "1605172", "1654954", "1654955"], "spl_set_id": ["0fd36cb9-c4f6-4167-93c9-8530865db3f9"], "pharm_class_cs": ["Erythropoietin [CS]"], "pharm_class_pe": ["Increased Erythroid Cell Production [PE]"], "pharm_class_epc": ["Erythropoiesis-stimulating Agent [EPC]"], "manufacturer_name": ["Amgen Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 PACKAGE (55513-023-04)  / 4 SYRINGE in 1 BLISTER PACK / .3 mL in 1 SYRINGE (55513-023-01)", "package_ndc": "55513-023-04", "marketing_start_date": "20060814"}], "brand_name": "ARANESP", "product_id": "55513-023_317b2b26-f30d-4a72-8667-780806d4c5b5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Erythropoiesis-stimulating Agent [EPC]", "Erythropoietin [CS]", "Increased Erythroid Cell Production [PE]"], "product_ndc": "55513-023", "generic_name": "darbepoetin alfa", "labeler_name": "Amgen Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ARANESP", "active_ingredients": [{"name": "DARBEPOETIN ALFA", "strength": "60 ug/.3mL"}], "application_number": "BLA103951", "marketing_category": "BLA", "marketing_start_date": "20060814", "listing_expiration_date": "20261231"}